Kissei Pharmaceutical Co., Ltd. is engaged in the research, development, manufacture and sale of pharmaceutical products primarily in Japan. Offers Urief and Urief OD tablets for the treatment of dysuria; Glufast, Glubes and Marizev tablets for type 2 diabetes; Darbepoetin Alfa BS and Epoetin Alfa BS injections for the treatment of renal anemia; Beova tablets for the treatment of overactive bladder; P-TOL chewable tablets for the treatment of hyperphosphatemia; and Minirin Melt OD tablets for nocturia due to nocturnal polyuria in men, central diabetes insipidus, and nocturnal enuresis were the result of decreased urine osmolality. The company’s products under development include KPS-0373, that it has completed the phase III clinical trial to treat spinocerebellar ataxia; CCX168, which has completed the phase III clinical trial for the treatment of microscopic polyangiitis and granulomatosis with polyangiitis; AJM300, which is in a phase III clinical trial to treat ulcerative colitis; R788 which is in a phase III clinical trial to treat chronic idiopathic thrombocytopenic purpura; and MR13A9, which is in a phase III clinical trial to treat uremic pruritus in dialysis patients. It is also developing KLH-2109 for the treatment of endometriosis and uterine fibroids; KDT-3594 for the treatment of Parkinson’s disease; Silodosin for dysuria associated with benign prostatic hyperplasia; Mitiglinide for type 2 diabetes mellitus; and Bedoradrine for the treatment of acute exacerbation of asthma. In addition, it develops and commercializes foods controlled in proteins and with energetic contribution; and buys and sells related materials, as well as provides information processing and systems development, construction contracting, equipment and facilities management, and information gathering and development support services. The company was previously known as Kissei Yakuhin Kogyo Co., Ltd. and changed its name to Kissei Pharmaceutical Co., Ltd. in October 1964. The company was founded in 1946 and is headquartered in Matsumoto, Japan. as well as offering systems development and information processing, construction contracting, equipment and facilities management, and data collection and development support services. The company was previously known as Kissei Yakuhin Kogyo Co., Ltd. and changed its name to Kissei Pharmaceutical Co., Ltd. in October 1964. The company was founded in 1946 and is headquartered in Matsumoto, Japan. as well as offering systems development and information processing, construction contracting, equipment and facilities management, and data collection and development support services. The company was previously known as Kissei Yakuhin Kogyo Co., Ltd. and changed its name to Kissei Pharmaceutical Co., Ltd. in October 1964. The company was founded in 1946 and is headquartered in Matsumoto, Japan.
How to buy Kissei Pharmaceutical (KIS.F) shares | walkthrough guide
Interested in getting Kissei Pharmaceutical (KIS.F) shares in Frankfurt risk-free and through a regulated broker? Would you like to be able to invest your profits per month and get capital gains on the stock market? Here I am going to show you how you can create an account in DEGIRO , a reliable investment platform and low commissions, and how you can get your first share of the company Kissei Pharmaceutical Co., Ltd. (KIS.F) (KIS. F) quickly and easily.
The method to follow is very intuitive :
- The first step is that we are going to register in DEGIRO, a platform where we are going to buy shares of the company Kissei Pharmaceutical Co., Ltd. (KIS.F), (KIS.F).
- Secondly, we will transfer €€€ and thus carry out the first investment in the stock market.
- When we see the funds in our account we will have to look for the company Kissei Pharmaceutical looking for its TICKER, which is KIS.F.
- To finish, we will only go on to indicate the number of shares that we will buy, the price and type of order.
It is possible that this checklist has been a bit essential for you, so I am going to show you the process with images.
How to open an account with DEGIRO
To start we are going to register in degiro in the following link :
It will require an email, a username and a password to access, and then we must continue with the link that they have sent us by email.
Now DEGIRO is going to require some data of interest to confirm our document . We must have at hand our passport, ID or driving license, your mobile and the account number that we will place to make our 1st deposit. If you have no idea what form this format is, you can check this simple post of instructions that we elaborated from Educaceps.es .
Once our account is validated we can put money from the Deposit/Withdraw tab. We will be able to make a bank transfer that will take more or less 1 to 2 days, or proceed to make the deposit quickly using Sofort, a completely secure and reliable payment gateway.
How to buy Kissei Pharmaceutical (KIS.F) shares through DEGIRO
As soon as we have the capital we have the possibility of buying our 1st share. You can select the place order button that you will find in a corner or use the spin finder and put the ticker. In the following image you will find that I have used the Amazon Ticker but in your case you should write (KIS.F), the Kissei Pharmaceutical ticker. As we are talking about an action, we will discover that the related tickers are listed and there we will see Kissei Pharmaceutical. The most fundamental thing is that the ticker, the name of the action and the market in which it is listed coincide. Amazon is listed on NASDAQ (NDQ) and in your case Kissei Pharmaceutical Co., Ltd. (KIS.F) is listed in Frankfurt. This step is essential so do not make mistakes.
At the time of placing the order we will have to pay attention to what I will explain to you . We can place a limit or market order. Imagine that you want to get a share of Kissei Pharmaceutical, but its price is currently too high. With a limit order we will enter the value at which we wish to make the purchase and until there are no shares for sale at this price, the share will not be purchased. With a market order, DeGiro will buy the number of shares that we have indicated at today’s selling price, which will be very similar to today’s trading price.
In any circumstance it is very essential that you look at the type of alignment: fixed or of the day . To give an example, in Spain, the stock market price is from tomorrow until 1:00 p.m., and in the US it corresponds to the afternoon schedule in Spain. If the order is fixed, it will be there until it can be executed, but if you select the “of the day” option, at the end of the day, if it is not carried out, it will be deleted from your Activity – Pending Orders section.
I hope that this detailed post has helped you to invest in Kissei Pharmaceutical. Thank you!
| Company information |
|
key executives
| Name | Title | Salary | exercised | Year of birth |
|---|---|---|---|---|
| Mr. Mutsuo Kanzawa | President and CEO | N/A | N/A | N/A |
| Mr. Yoshio Furihata | Pres, COO and Director | N/A | N/A | N/A |
| Mr. Hiroe Sato | Exec. Vice President and Director | N/A | N/A | N/A |
| Mr. Masaki Morozumi | Director and Advisor Mr. | N/A | N/A | 1952 |
| Mr. Keiji Fukushima | Exec. MD and Director | N/A | N/A | N/A |
| Mr. Yasuo Takehana | MD and Director | N/A | N/A | N/A |
| Mr. Tetsu Takayama | MD and Director | N/A | N/A | N/A |
Recent events of :
We have no recent events for this company.